Free Trial

Cyclacel Pharmaceuticals (CYCC) Short Interest Ratio & Short Volume

Cyclacel Pharmaceuticals logo
$0.36 +0.01 (+2.89%)
(As of 11/22/2024 ET)

Cyclacel Pharmaceuticals Short Interest Data

Cyclacel Pharmaceuticals (CYCC) has a short interest of 66,800 shares, representing 3.26% of the float (the number of shares available for trading by the public). This marks a 83.01% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 1.55 million shares to cover all short positions.

Current Short Interest
66,800 shares
Previous Short Interest
36,500 shares
Change Vs. Previous Month
+83.01%
Dollar Volume Sold Short
$43,353.20
Short Interest Ratio
0.1 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
6,290,000 shares
Float Size
2,050,000 shares
Short Percent of Float
3.26%
Today's Trading Volume
260,562 shares
Average Trading Volume
1,549,094 shares
Today's Volume Vs. Average
17%
Short Selling Cyclacel Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CYCC Short Interest Over Time

CYCC Days to Cover Over Time

CYCC Percentage of Float Shorted Over Time

Cyclacel Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202466,800 shares $43,353.20 +83.0%3.3%0.1 $0.65
10/15/202436,500 shares $31,390.00 -23.8%1.8%0 $0.86
9/30/202447,900 shares $47,421.00 +0.6%2.5%0.8 $0.99
9/15/202447,600 shares $48,076.00 -14.9%2.5%0.7 $1.01
8/31/202455,900 shares $58,806.80 +3.0%3.0%0.7 $1.05
8/15/202454,300 shares $71,676.00 -18.6%2.9%0.4 $1.32
7/31/202466,700 shares $112,056.00 -41.0%4.9%0.5 $1.68
7/15/2024113,100 shares $196,794.00 -32.4%8.3%0.1 $1.74
6/30/2024167,300 shares $271,026.00 +8.1%12.2%0.2 $1.62
6/15/2024154,700 shares $261,443.00 +63.7%11.3%0.2 $1.69
5/31/202494,500 shares $249,480.00 -35.0%6.9%0.1 $2.64
5/15/2024145,300 shares $354,532.00 -58.6%10.6%0.2 $2.44
4/30/2024351,100 shares $744,332.00 +814.3%29.3%0.5 $2.12
4/15/202438,400 shares $60,672.00 +58.0%3.2%0.8 $1.58
3/31/202424,300 shares $51,270.57 -8.7%2.0%0.2 $2.11
3/15/202426,600 shares $64,638.00 -35.9%2.2%0.2 $2.43
2/29/202441,500 shares $106,240.00 -44.5%3.6%0.2 $2.56
2/15/202474,800 shares $198,968.00 -10.0%6.4%0.5 $2.66
1/31/202483,100 shares $186,144.00 +0.7%9.3%0.5 $2.24
1/15/202482,500 shares $194,700.00 +129.2%9.1%0.6 $2.36
12/31/202336,000 shares $96,120.00 -13.3%4.0%0.3 $2.67
12/15/202341,500 shares $148,466.25 -92.2%5.9%1.3 $3.58
11/30/2023530,900 shares $159,270.00 +2.5%5.0%3 $0.30
11/15/2023518,200 shares $179,297.20 +1.2%4.9%3.6 $0.35
10/31/2023512,300 shares $275,924.78 +1.1%4.8%4.1 $0.54
10/15/2023506,900 shares $316,305.60 +3.7%4.7%4.3 $0.62
9/30/2023488,800 shares $173,377.36 +7.1%4.5%5.2 $0.35
9/15/2023456,600 shares $148,349.34 +7.0%4.2%4.9 $0.32
8/31/2023426,900 shares $169,052.40 +4.9%4.0%4.3 $0.40
8/15/2023406,800 shares $190,382.40 -7.6%3.8%5.4 $0.47
7/31/2023440,100 shares $294,426.90 -0.5%4.1%6.3 $0.67
7/15/2023442,100 shares $259,114.81 +1.5%4.1%6.1 $0.59
6/30/2023435,400 shares $256,494.14 -1.8%4.0%7.7 $0.59
6/15/2023443,400 shares $297,477.06 -12.7%4.1%7.5 $0.67
5/31/2023508,000 shares $325,120.00 +5.5%4.7%9.9 $0.64
5/15/2023481,400 shares $260,629.96 No Change4.4%8.1 $0.54
10/31/2022461,800 shares $641,902.00 +15.6%N/A0.9 $1.39
10/15/2022399,400 shares $519,220.00 -15.6%N/A0.6 $1.30
9/30/2022473,000 shares $690,580.00 +16.7%N/A0.5 $1.46
9/15/2022405,500 shares $640,690.00 -44.1%N/A0.4 $1.58
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
8/31/2022725,400 shares $1.22 million -43.8%N/A0.6 $1.68
8/15/20221,290,000 shares $2.04 million +50.6%N/A1.1 $1.58
7/31/2022856,400 shares $976,296.00 +46.7%N/A1.1 $1.14
7/15/2022583,900 shares $712,358.00 +147.5%N/A0.9 $1.22
6/30/2022235,900 shares $254,772.00 -5.5%2.6%0.5 $1.08
6/15/2022249,500 shares $279,440.00 +10.0%2.8%0.9 $1.12
5/31/2022226,800 shares $272,160.00 -18.6%2.8%1.1 $1.20
5/15/2022278,500 shares $387,115.00 -23.9%3.4%2.1 $1.39
4/30/2022366,100 shares $684,607.00 -21.0%4.5%3 $1.87
4/15/2022463,600 shares $950,380.00 +53.4%5.7%3.7 $2.05
3/31/2022302,200 shares $921,710.00 -5.1%N/A7.2 $3.05
3/15/2022318,500 shares $863,135.00 -4.7%3.9%4.9 $2.71
2/28/2022334,100 shares $1.09 million -5.8%4.1%4.6 $3.25
2/15/2022354,500 shares $1.31 million -11.7%4.3%4.3 $3.69
1/31/2022401,300 shares $1.28 million -3.2%4.9%4.4 $3.18
1/15/2022414,400 shares $1.50 million +17.1%5.1%4.6 $3.62
12/31/2021353,800 shares $1.38 million -3.4%4.3%3.8 $3.89
12/15/2021366,200 shares $1.23 million -14.1%4.5%3.5 $3.36
11/30/2021426,100 shares $1.53 million -12.7%5.3%3.8 $3.58
11/15/2021488,300 shares $2.33 million -4.0%6.1%4.2 $4.78
10/29/2021508,600 shares $2.50 million -0.6%6.8%4.4 $4.91
10/15/2021511,600 shares $2.85 million -2.2%6.9%4.2 $5.57
9/30/2021523,300 shares $2.76 million +3.1%7.0%4.2 $5.27
9/15/2021507,400 shares $3.00 million +6.4%6.8%5.1 $5.91
8/31/2021476,800 shares $2.59 million -2.5%6.4%5.4 $5.44
8/13/2021488,800 shares $2.40 million -14.8%6.6%5.7 $4.90
7/30/2021573,900 shares $2.85 million -20.0%7.7%6 $4.96
7/15/2021717,600 shares $3.79 million -9.9%9.7%6.4 $5.28
6/30/2021796,400 shares $4.71 million +22.1%10.7%6.7 $5.92
6/15/2021652,200 shares $4.36 million -26.7%8.8%4.9 $6.69
5/28/2021890,200 shares $6.38 million +3.1%12.0%4.6 $7.17
5/14/2021863,800 shares $5.67 million +5.2%12.0%3.2 $6.56
4/30/2021821,000 shares $5.84 million -4.1%11.4%1.6 $7.11
4/15/2021856,300 shares $6.02 million -0.2%N/A0 $7.03
3/31/2021858,100 shares $5.73 million -11.3%13.6%1.2 $6.68
3/15/2021967,900 shares $7.31 million -7.8%15.4%1 $7.55
2/26/20211,050,000 shares $7.35 million +1.9%29.2%1.2 $7.00
2/12/20211,030,000 shares $9.98 million +26.4%28.6%1.2 $9.69
1/29/2021814,600 shares $6.19 million -16.2%16.2%1.1 $7.60
1/15/2021972,300 shares $8.76 million +9.6%19.3%2.2 $9.01
12/31/2020887,400 shares $6.34 million +319.2%17.7%2.1 $7.15
12/15/2020211,700 shares $908,193.00 +221.7%4.0%0.6 $4.29
11/30/202065,800 shares $253,330.00 -9.5%1.4%0.4 $3.85
11/15/202072,700 shares $257,358.00 -16.1%1.5%0.6 $3.54
10/30/202086,600 shares $296,172.00 +166.5%1.8%0.5 $3.42
10/15/202032,500 shares $134,062.50 -39.3%0.7%0.2 $4.13
9/30/202053,500 shares $195,275.00 +87.1%1.1%0.2 $3.65
9/15/202028,600 shares $98,670.00 -2.7%0.6%0.1 $3.45
8/31/202029,400 shares $112,308.00 -84.9%0.6%0.1 $3.82
8/14/2020194,300 shares $872,407.00 +50.9%4.0%0.6 $4.49
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
7/31/2020128,800 shares $637,560.00 -38.2%2.7%0.2 $4.95
7/15/2020208,500 shares $925,740.00 -10.8%4.3%0.3 $4.44
6/30/2020233,800 shares $1.08 million +6.1%4.9%0.3 $4.64
6/15/2020220,400 shares $996,208.00 -35.6%4.6%0.3 $4.52
5/29/2020342,200 shares $1.85 million +295.2%7.1%0.4 $5.40
5/15/202086,600 shares $355,926.00 -30.9%1.8%0.1 $4.11
4/30/2020125,400 shares $522,918.00 +1,040.0%15.1%0.3 $4.17
4/15/202011,000 shares $87,670.00 -92.2%1.3%0 $7.97
3/31/2020141,700 shares $569,634.00 +243.1%0.8%0.8 $4.02
3/13/202041,300 shares $16,107.00 +144.4%0.2%0.3 $0.39
2/28/202016,900 shares $5,577.00 -79.9%0.1%0.1 $0.33
2/14/202084,100 shares $40,368.00 -50.5%0.5%0.3 $0.48
1/31/2020169,900 shares $103,639.00 -43.2%1.0%0.7 $0.61
1/15/2020298,900 shares $215,208.00 -30.2%1.8%1.2 $0.72
12/31/2019427,900 shares $325,204.00 +30.5%2.5%1.9 $0.76

CYCC Short Interest - Frequently Asked Questions

What is Cyclacel Pharmaceuticals' current short interest?

Short interest is the volume of Cyclacel Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 66,800 shares of CYCC short. 3.26% of Cyclacel Pharmaceuticals' shares are currently sold short. Learn More on Cyclacel Pharmaceuticals' current short interest.

What is a good short interest percentage for Cyclacel Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.26% of Cyclacel Pharmaceuticals' floating shares are currently sold short.

Is Cyclacel Pharmaceuticals' short interest increasing or decreasing?

Cyclacel Pharmaceuticals saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 66,800 shares, an increase of 83.0% from the previous total of 36,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cyclacel Pharmaceuticals' float size?

Cyclacel Pharmaceuticals currently has issued a total of 6,290,000 shares. Some of Cyclacel Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclacel Pharmaceuticals currently has a public float of 2,050,000 shares.

How does Cyclacel Pharmaceuticals' short interest compare to its competitors?

3.26% of Cyclacel Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cyclacel Pharmaceuticals: Psyence Biomedical Ltd. (7.21%), Eterna Therapeutics Inc. (1.53%), Genprex, Inc. (14.95%), Processa Pharmaceuticals, Inc. (3.36%), Virpax Pharmaceuticals, Inc. (7.64%), Lipella Pharmaceuticals Inc. (0.23%), Avalon GloboCare Corp. (27.35%), Matinas Biopharma Holdings, Inc. (0.66%), SciSparc Ltd. (3.78%), Protagenic Therapeutics, Inc. (2.55%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Cyclacel Pharmaceuticals stock?

Short selling CYCC is an investing strategy that aims to generate trading profit from Cyclacel Pharmaceuticals as its price is falling. CYCC shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cyclacel Pharmaceuticals?

A short squeeze for Cyclacel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CYCC, which in turn drives the price of the stock up even further.

How often is Cyclacel Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYCC, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:CYCC) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners